+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Autoinjectors - Global Market Trajectory & Analytics

  • ID: 4804455
  • Report
  • September 2020
  • Region: Global
  • 189 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • ABBVIE
  • AMNEAL PHARMACEUTICALS
  • APTARGROUP, INC.
  • ELI LILLY AND COMPANY
  • MYLAN NV
  • SHL GROUP
  • MORE
Global Autoinjectors Market to Reach $118.6 Billion by 2027

Amid the COVID-19 crisis, the global market for Autoinjectors estimated at US$35.1 Billion in the year 2020, is projected to reach a revised size of US$118.6 Billion by 2027, growing at a CAGR of 19% over the analysis period 2020-2027. Rheumatoid Arthritis, one of the segments analyzed in the report, is projected to record a 20.8% CAGR and reach US$43.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Multiple Sclerosis segment is readjusted to a revised 18.7% CAGR for the next 7-year period.

The U. S. Market is Estimated at $9.5 Billion, While China is Forecast to Grow at 24.1% CAGR

The Autoinjectors market in the U. S. is estimated at US$9.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$28 Billion by the year 2027 trailing a CAGR of 24.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.7% and 17.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 16.3% CAGR.

Anaphylaxis Segment to Record 18.1% CAGR

In the global Anaphylaxis segment, USA, Canada, Japan, China and Europe will drive the 17.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$4.4 Billion in the year 2020 will reach a projected size of US$13.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$17.3 Billion by the year 2027, while Latin America will expand at a 19.4% CAGR through the analysis period. We bring years of research experience to this 4th edition of our report. The 189-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • AbbVie, Inc.
  • Amgen, Inc.
  • Antares Pharma, Inc.
  • Becton, Dickinson and Company
  • Consort Medical PLC
  • Eli Lilly and Company
  • Haselmeier GmbH
  • Mylan NV
  • Owen Mumford Ltd.
  • SHL Group
  • Teva Pharmaceutical Industries Ltd.
  • Ypsomed AG
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • ABBVIE
  • AMNEAL PHARMACEUTICALS
  • APTARGROUP, INC.
  • ELI LILLY AND COMPANY
  • MYLAN NV
  • SHL GROUP
  • MORE
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Rapid Shift from Self-Injectors to Autoinjectors for Easy and Safe Administration of DrugsDrives Demand
  • North America: The Largest Market for Autoinjectors
  • Global Competitor Market Shares
  • Autoinjectors Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Global Epinephrine Autoinjector market: Percentage Breakdown of Volume Salesby Leading Players for the Year 2019E
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Targeted Therapies such as Cancer, Rheumatoid Arthritis, Multiple Sclerosisand Diabetes: A Strong Growth Driver
  • Number of New Cases of Cancer Worldwide for the Years 2012, 2015, 2020, 2025 and 2030
  • Diabetes Prevalence in the Age-Group of 20-79 Years in Millions by Region for the Years 2018, 2021 and 2025
  • Global Injectable Drug Delivery Market: Revenues in US$ Billion for the Years 2016, 2018, 2020, 2022 and 2024
  • Rising Incidence of Anaphylaxis and Increased Prescription Rate of Epinephrine AutoinjectorsBoosts Market Demand
  • Increasing Number of Regulatory Approvals for Autoinjectors in Various Diseases
  • Generic Autoinjectors Take Center Stage
  • Patent Expiry of Biologics to Drive the Demand for Biosimilars
  • Strong Government Support and Favorable Reimbursement Policies Propel Market Growth
  • Challenges
  • Development of Autoinjectors for Multiple Drug Viscosities: A Major Challenge
  • Increasing Demand for Alternative Drug Delivery Modes Hampers Market Growth
  • Emergence of Oral Diabetic Agents, Oral Insulin and Epinephrine Nasal Sprays Poses Huge Challenge for Autoinjectors Market
  • Product Overview
  • Autoinjector: Definition
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: Autoinjectors Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Autoinjectors Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Autoinjectors Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Rheumatoid Arthritis (Therapy) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: Rheumatoid Arthritis (Therapy) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: Rheumatoid Arthritis (Therapy) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Multiple Sclerosis (Therapy) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: Multiple Sclerosis (Therapy) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: Multiple Sclerosis (Therapy) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Anaphylaxis (Therapy) Geographic Market Spread Worldwide in US$ Million:2020 to 2027
  • TABLE 11: Anaphylaxis (Therapy) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
  • TABLE 12: Anaphylaxis (Therapy) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Diabetes (Therapy) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
  • TABLE 14: Diabetes (Therapy) Market Historic Review by Region/Country in US$ Million:2012 to 2019
  • TABLE 15: Diabetes (Therapy) Market Share Breakdown by Region/Country:2012 VS 2020 VS 2027
  • TABLE 16: Other Therapies (Therapy) World Market by Region/Country in US$ Million:2020 to 2027
  • TABLE 17: Other Therapies (Therapy) Historic Market Analysis by Region/Countryin US$ Million: 2012 to 2019
  • TABLE 18: Other Therapies (Therapy) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US Autoinjectors Market Share (in %) by Company: 2019 & 2025
  • Market Analytics
  • TABLE 19: United States Autoinjectors Market Estimates and Projections in US$ Million by Therapy: 2020 to 2027
  • TABLE 20: Autoinjectors Market in the United States by Therapy: A Historic Review in US$ Million for 2012-2019
  • TABLE 21: United States Autoinjectors Market Share Breakdown by Therapy: 2012 VS 2020 VS 2027
CANADA
  • TABLE 22: Canadian Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2020 to 2027
  • TABLE 23: Canadian Autoinjectors Historic Market Review by Therapy in US$ Million: 2012-2019
  • TABLE 24: Autoinjectors Market in Canada: Percentage Share Breakdown of Sales by Therapy for 2012, 2020, and 2027
JAPAN
  • TABLE 25: Japanese Market for Autoinjectors: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2020-2027
  • TABLE 26: Autoinjectors Market in Japan: Historic Sales Analysis in US$ Million by Therapy for the Period 2012-2019
  • TABLE 27: Japanese Autoinjectors Market Share Analysis by Therapy: 2012 VS 2020 VS 2027
CHINA
  • TABLE 28: Chinese Autoinjectors Market Growth Prospects in US$ Million by Therapy for the Period 2020-2027
  • TABLE 29: Autoinjectors Historic Market Analysis in China in US$ Million by Therapy: 2012-2019
  • TABLE 30: Chinese Autoinjectors Market by Therapy: Percentage Breakdown of Sales for 2012, 2020, and 2027
EUROPE
  • Market Facts & Figures
  • European Autoinjectors Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Market Analytics
  • TABLE 31: European Autoinjectors Market Demand Scenario in US$ Million by Region/Country: 2020-2027
  • TABLE 32: Autoinjectors Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
  • TABLE 33: European Autoinjectors Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 34: European Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2020-2027
  • TABLE 35: Autoinjectors Market in Europe in US$ Million by Therapy: A Historic Review for the Period 2012-2019
  • TABLE 36: European Autoinjectors Market Share Breakdown by Therapy: 2012 VS 2020 VS 2027
FRANCE
  • TABLE 37: Autoinjectors Market in France by Therapy: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 38: French Autoinjectors Historic Market Scenario in US$ Million by Therapy: 2012-2019
  • TABLE 39: French Autoinjectors Market Share Analysis by Therapy: 2012 VS 2020 VS 2027
GERMANY
  • TABLE 40: Autoinjectors Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2020-2027
  • TABLE 41: German Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2012-2019
  • TABLE 42: German Autoinjectors Market Share Breakdown by Therapy: 2012 VS 2020 VS 2027
ITALY
  • TABLE 43: Italian Autoinjectors Market Growth Prospects in US$ Million by Therapy for the Period 2020-2027
  • TABLE 44: Autoinjectors Historic Market Analysis in Italy in US$ Million by Therapy: 2012-2019
  • TABLE 45: Italian Autoinjectors Market by Therapy: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED KINGDOM
  • TABLE 46: United Kingdom Market for Autoinjectors: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2020-2027
  • TABLE 47: Autoinjectors Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapy for the Period 2012-2019
  • TABLE 48: United Kingdom Autoinjectors Market Share Analysis by Therapy:2012 VS 2020 VS 2027
SPAIN
  • TABLE 49: Spanish Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2020 to 2027
  • TABLE 50: Spanish Autoinjectors Historic Market Review by Therapy in US$ Million: 2012-2019
  • TABLE 51: Autoinjectors Market in Spain: Percentage Share Breakdown of Sales by Therapy for 2012, 2020, and 2027
RUSSIA
  • TABLE 52: Russian Autoinjectors Market Estimates and Projections in US$ Million by Therapy: 2020 to 2027
  • TABLE 53: Autoinjectors Market in Russia by Therapy: A Historic Review in US$ Million for 2012-2019
  • TABLE 54: Russian Autoinjectors Market Share Breakdown by Therapy: 2012 VS 2020 VS 2027
REST OF EUROPE
  • TABLE 55: Rest of Europe Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2020-2027
  • TABLE 56: Autoinjectors Market in Rest of Europe in US$ Million by Therapy: A Historic Review for the Period 2012-2019
  • TABLE 57: Rest of Europe Autoinjectors Market Share Breakdown by Therapy: 2012 VS 2020 VS 2027
ASIA-PACIFIC
  • TABLE 58: Asia-Pacific Autoinjectors Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 59: Autoinjectors Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
  • TABLE 60: Asia-Pacific Autoinjectors Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 61: Autoinjectors Market in Asia-Pacific by Therapy: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 62: Asia-Pacific Autoinjectors Historic Market Scenario in US$ Million by Therapy: 2012-2019
  • TABLE 63: Asia-Pacific Autoinjectors Market Share Analysis by Therapy: 2012 VS 2020 VS 2027
AUSTRALIA
  • TABLE 64: Autoinjectors Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2020-2027
  • TABLE 65: Australian Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2012-2019
  • TABLE 66: Australian Autoinjectors Market Share Breakdown by Therapy: 2012 VS 2020 VS 2027
INDIA
  • TABLE 67: Indian Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2020 to 2027
  • TABLE 68: Indian Autoinjectors Historic Market Review by Therapy in US$ Million: 2012-2019
  • TABLE 69: Autoinjectors Market in India: Percentage Share Breakdown of Sales by Therapy for 2012, 2020, and 2027
SOUTH KOREA
  • TABLE 70: Autoinjectors Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2020-2027
  • TABLE 71: South Korean Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2012-2019
  • TABLE 72: Autoinjectors Market Share Distribution in South Korea by Therapy: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
  • TABLE 73: Rest of Asia-Pacific Market for Autoinjectors: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2020-2027
  • TABLE 74: Autoinjectors Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Therapy for the Period 2012-2019
  • TABLE 75: Rest of Asia-Pacific Autoinjectors Market Share Analysis by Therapy: 2012 VS 2020 VS 2027
LATIN AMERICA
  • TABLE 76: Latin American Autoinjectors Market Trends by Region/Country in US$ Million: 2020-2027
  • TABLE 77: Autoinjectors Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
  • TABLE 78: Latin American Autoinjectors Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
  • TABLE 79: Latin American Autoinjectors Market Growth Prospects in US$ Million by Therapy for the Period 2020-2027
  • TABLE 80: Autoinjectors Historic Market Analysis in Latin America in US$ Million by Therapy: 2012-2019
  • TABLE 81: Latin American Autoinjectors Market by Therapy: Percentage Breakdown of Sales for 2012, 2020, and 2027
ARGENTINA
  • TABLE 82: Argentinean Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2020-2027
  • TABLE 83: Autoinjectors Market in Argentina in US$ Million by Therapy: A Historic Review for the Period 2012-2019
  • TABLE 84: Argentinean Autoinjectors Market Share Breakdown by Therapy: 2012 VS 2020 VS 2027
BRAZIL
  • TABLE 85: Autoinjectors Market in Brazil by Therapy: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 86: Brazilian Autoinjectors Historic Market Scenario in US$ Million by Therapy: 2012-2019
  • TABLE 87: Brazilian Autoinjectors Market Share Analysis by Therapy: 2012 VS 2020 VS 2027
MEXICO
  • TABLE 88: Autoinjectors Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2020-2027
  • TABLE 89: Mexican Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2012-2019
  • TABLE 90: Mexican Autoinjectors Market Share Breakdown by Therapy: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
  • TABLE 91: Rest of Latin America Autoinjectors Market Estimates and Projections in US$ Million by Therapy: 2020 to 2027
  • TABLE 92: Autoinjectors Market in Rest of Latin America by Therapy: A Historic Review in US$ Million for 2012-2019
  • TABLE 93: Rest of Latin America Autoinjectors Market Share Breakdown by Therapy: 2012 VS 2020 VS 2027
MIDDLE EAST
  • TABLE 94: The Middle East Autoinjectors Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 95: Autoinjectors Market in the Middle East by Region/Country in US$ Million:2012-2019
  • TABLE 96: The Middle East Autoinjectors Market Share Breakdown by Region/Country: 2012, 2020, and 2027
  • TABLE 97: The Middle East Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2020 to 2027
  • TABLE 98: The Middle East Autoinjectors Historic Market by Therapy in US$ Million:2012-2019
  • TABLE 99: Autoinjectors Market in the Middle East: Percentage Share Breakdown of Sales by Therapy for 2012,2020, and 2027
IRAN
  • TABLE 100: Iranian Market for Autoinjectors: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2020-2027
  • TABLE 101: Autoinjectors Market in Iran: Historic Sales Analysis in US$ Million by Therapy for the Period 2012-2019
  • TABLE 102: Iranian Autoinjectors Market Share Analysis by Therapy:2012 VS 2020 VS 2027
ISRAEL
  • TABLE 103: Israeli Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2020-2027
  • TABLE 104: Autoinjectors Market in Israel in US$ Million by Therapy: A Historic Review for the Period 2012-2019
  • TABLE 105: Israeli Autoinjectors Market Share Breakdown by Therapy: 2012 VS 2020 VS 2027
SAUDI ARABIA
  • TABLE 106: Saudi Arabian Autoinjectors Market Growth Prospects in US$ Million by Therapy for the Period 2020-2027
  • TABLE 107: Autoinjectors Historic Market Analysis in Saudi Arabia in US$ Million by Therapy: 2012-2019
  • TABLE 108: Saudi Arabian Autoinjectors Market by Therapy: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED ARAB EMIRATES
  • TABLE 109: Autoinjectors Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2020-2027
  • TABLE 110: United Arab Emirates Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2012-2019
  • TABLE 111: Autoinjectors Market Share Distribution in United Arab Emirates by Therapy: 2012 VS 2020 VS 2027
REST OF MIDDLE EAST
  • TABLE 112: Autoinjectors Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2020-2027
  • TABLE 113: Rest of Middle East Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2012-2019
  • TABLE 114: Rest of Middle East Autoinjectors Market Share Breakdown by Therapy: 2012 VS 2020 VS 2027
AFRICA
  • TABLE 115: African Autoinjectors Market Estimates and Projections in US$ Million by Therapy: 2020 to 2027
  • TABLE 116: Autoinjectors Market in Africa by Therapy: A Historic Review in US$ Million for 2012-2019
  • TABLE 117: African Autoinjectors Market Share Breakdown by Therapy:2012 VS 2020 VS 2027
IV. COMPETITION
  • Total Companies Profiled: 42
Note: Product cover images may vary from those shown
3 of 3
  • ABBVIE
  • ANTARES PHARMA, INC.
  • CONSORT MEDICAL PLC
  • ELI LILLY AND COMPANY
  • HASELMEIER GMBH
  • MYLAN NV
  • OWEN MUMFORD
  • SHL GROUP
  • TEVA PHARMACEUTICAL INDUSTRIES
  • YPSOMED AG
  • ALK-ABELLO AS
  • AMNEAL PHARMACEUTICALS
  • APTARGROUP, INC.
Note: Product cover images may vary from those shown
Adroll
adroll